Post-exposure Prophylaxis for HIV, HBV and HCV: Integrated Protocol for Managing Exposures to Blood and Body Fluids in Manitoba
Click on any of the sections in the following Table of Contents, and the corresponding page of the PDF version of the Protocol will open in a new browser window. You can then either print that specific page, or you may choose to print the entire Protocol.
Table of Contents
Letter to HCP - Re: HIV PEP medications coverage under the Manitoba HIV Medications Program
Medication Coverage and Prescription Form for HIV PEP
Changes from the May 2019 Version
Changes from the October 2018 Version
1. Overview
2. Initial Non-Specific Prophylactic Measures and Risk Assessment
2.1 Initial Assessment and Reporting of Exposure Incident
2.1.1. Occupational Exposures
2.1.2. Non-Occupational Exposures
2.2 Risk Assessment of Exposure Incident for Consideration of PEP
2.2.1. Body Fluid Involved
2.2.2. Type of Exposure
2.2.3. Status of Source
3. HIV PEP
3.1. Provision of HIV Prophylaxis
3.2. HIV Laboratory Testing
4. HBV PEP
4.1. Provision of HBV Prophylaxis
4.2. HBV Laboratory Testing
5. HCV PEP
5.1. No Available HCV Prophylaxis
5.2 HCV Laboratory Testing
6. References
Appendix A - HIV Post-exposure Prophylaxis Starter Kits
Appendix B - Laboratory Testing
Appendix C - Important Contact Numbers and Useful Web Links in Manitoba
Communicable Disease
Control (CDC) Health Links – Info Santé |
